Black Diamond Therapeutics, Inc. Common Stock (BDTX) is a publicly traded Healthcare sector company. As of September 22, 2026, BDTX trades at $1.95 with a market cap of $112.61M and a P/E ratio of 4.96. BDTX moved -1.02% today. Year to date, BDTX is -19.75%; over the trailing twelve months it is -40.55%. Its 52-week range spans $1.20 to $4.94. Analyst consensus is strong buy with an average price target of $10.33. Rallies surfaces BDTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
7 analysts cover BDTX: 0 strong buy, 7 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $10.33.
| Metric | Value |
|---|---|
| Price | $1.95 |
| Market Cap | $112.61M |
| P/E Ratio | 4.96 |
| EPS | $0.39 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.94 |
| 52-Week Low | $1.20 |
| Volume | 728.49K |
| Avg Volume | 0 |
| Revenue (TTM) | $70.00M |
| Net Income | $22.37M |
| Gross Margin | 0.00% |
7 analysts cover BDTX: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.33.